Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...
US-based Pillar Biosciences, Inc., LC-SCRUM-Asia and LSI Medience Corporation have announced a collaboration to support ...
Japan-based Chugai Pharmaceutical has signed an exclusive license agreement with British pharma firm GlaxoSmithKline (GS...
LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an...
Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, has entered ...
German technology consulting and IT services company adesso SE and Japan-based Hitachi Digital Services have announ...
Japan-based Chugai Pharmaceutical and the University of California, San Francisco (UCSF) have entere...
Counterfeit and unauthorised healthcare products remain a persistent risk across Asia, particularly where fragmented dis...
Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of...
The collaboration between Monash, Australia’s largest university, leading Japanese information technology company ...
J-Pharma has built its pipeline around amino acid transporter (LAT1)-targeted therapies. What was the vision behind this...
Ember LifeSciences, Inc. has entered into a capital and business alliance with Alfresa Corporation, a subsidiary of Alfr...
Japan-based Ono Pharmaceutical and US-based Phylo, Inc. have announced a collaboration that brings Biomni Lab, Phylo's a...
Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...
A growing burden demands a new approach Cardiac ablation treats AFib by targeting heart cells that send erratic signals...
Japan-based Shimadzu Corporation has announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatogra...
Japan's Global Health Innovative Technology (GHIT) Fund has announced an investment of JPY 140 million (approximately $8...
US-based BostonGene, the developer of the leading AI model for tumour and immune biology, has announced a strategic...
JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies for rare and gen...
Rege Nephro, a clinical-stage biotechnology startup focused on induced pluripotent stem (iPS) cell-based kidney regenera...
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC reg...
Japan-based Dai Nippon Printing (DNP) has signed a share purchase agreement to acquire Kyowa Pharma Chemical, an act...
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 2.86 billion (...
South Korea-based startup Boostimmune has secured a Japanese patent covering technology that uses antibodies to inhibit ...
Japan-based Shimadzu Corporation has completed the acquisition of all shares of Glass HoldCo s.r.o., which indirectly ho...
